CooperSurgical
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Trumbull, Connecticut, United States, North America
Region: Connecticut
Country: US
Continent: North America
About
CooperSurgical is a global medical devices company focused on advancing women’s health and fertility. The company develops and provides a broad portfolio of products and brands spanning reproductive care, fertility technology, gynecological surgery, and related diagnostics to healthcare providers and patients worldwide. With initiatives across fertility preservation, donor programs, and endoscopy and labor-and-delivery solutions, CooperSurgical serves clinics and hospitals in the United States and internationally. The organization emphasizes education, quality certifications, and support services to improve patient outcomes in women’s health and fertility care.
CooperSurgical is a medical device company specializing in women's health, fertility, and genomics products. It manufactures and distributes instruments for obstetrics, gynecology, and reproductive care to healthcare providers globally. The company supports clinics and hospitals with tools for diagnostics, surgery, and fertility preservation.
CooperSurgical, Inc.
1990
for_profit
active
Industries
Primary Industry: Manufacturing
Categories
Funding & Financials
Late Stage
$1.5B
over-1b
ipo
Investors
Founders
Holly Sheffield
Leadership
Technology Stack
Products
Paragard® Intrauterine Copper Contraceptive: A copper-containing intrauterine device (IUD) for pregnancy prevention in females of reproductive potential for up to 10 years.
Donor Egg and Sperm Services: Provision of high-quality donor egg and sperm with screening, financing, and storage options to support family planning.
Assisted Reproductive Technology (ART) Products: A range of products supporting IVF and fertility clinics including media, incubators, workstations, genetic tests, and cryopreservation solutions.
Newborn Stem Cell Preservation Services: Services for collection, processing, and storage of newborn stem cells from cord blood to provide future medical options.
Labor and Delivery Products: Medical devices for labor and delivery including fetal head elevation, skin closure, and postpartum bleeding control.
Women’s Health Diagnostic and Treatment Products: Diagnostic tools and treatment options for uterine health, abnormal bleeding, and gynecological conditions.
Funding rounds
Post Ipo Equity · (2025-10-19) · Lead: JANA Partners
IPO · (2023-09-26)
Post Ipo Equity · $1.5B · (2021-12-17)